证券代码：524666 证券简称：26 皖能 G1 安徽省皖能股份有限公司 2026 年面向专业投资者公开发行 绿色公司债券（第一期）票面利率公告 本公司及其全体董事、高级管理人员或履行同等职责的人员承诺本募集说明 书信息披露真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 (本页无正文,为《安徽省皖能股份有限公司 2026 年面向专业投资者公开 发行绿色公司债券（第一期）票面利率公告》之盖章页） 安徽省皖能股份有限公司（以下简称"发行人"）发行不超过人民币 99 亿元 公司债券已获得中国证券监督管理委员会证监许可【2026】20 号文注册。安徽 省皖能股份有限公司 2026 年面向专业投资者公开发行绿色公司债券（第一期） （以下简称"本期债券"）拟发行规模不超过 10 亿元（含 10 亿元），发行期限为 3 年。 2026 年【 投资者进行了票面利率询价，利率询价区间为【1.50】%- 2】月【6 】日，发行人和主承销商通过簿记建档系统向专业机构 【2.50】%。根据网下 向专业机构投资者询价结果，经发行人和主承销商协商一致，最终确定本期债券 票面利率为【1.80】%。 发行人将按上述票面利率于 2 ...

Group 1 - The company announced the appointment of Xu Wengong as the new General Manager following the resignation of Fang Shiqing due to work adjustments [2] - The board of directors approved Xu Wengong as a candidate for the 11th board of directors and appointed him as the General Manager [2] Group 2 - Waneng Power is one of the first batch of standardized restructured listed companies in Anhui Province, listed on the Shenzhen Stock Exchange in December 1993 [4] - The company serves as the overall operating platform for the power main assets of Waneng Group, focusing on building a first-class power industry platform [4] - Waneng Power adheres to a business development strategy centered on electricity, continuously optimizing thermal power development while strategically advancing wind, hydro, and nuclear power as clean energy sources [4] - As of the end of 2024, the company's total assets amounted to 66.6 billion yuan [4]

Group 1 - The core point of the article is the announcement by WanNeng Power regarding the resignation of Mr. Fang Shiqing from his positions as a director and general manager due to work adjustments [1] - The board of directors approved the nomination of Mr. Xu Wengong as a candidate for the 11th board of directors and appointed him as the general manager, with his term starting from the date of the board resolution until the end of the current board's term [1]

证券日报网讯2月5日，皖能电力（000543）发布公告称，因工作调整，方世清先生申请辞去公司董事及 总经理职务，此后将不在公司担任任何职务；其辞职报告自送达董事会之日起生效，辞职不影响公司经 营管理正常运行。 ...

安徽省皖能股份有限公司 主体长期信用评级报告 | | | www.lhratings.com 1 联合〔2025〕1213 号 联合资信评估股份有限公司通过对安徽省皖能股份有限公司的 信用状况进行综合分析和评估，确定安徽省皖能股份有限公司主体 长期信用等级为 AAA，评级展望为稳定。 特此公告 联合资信评估股份有限公司 二〇二五年三月十四日 信用评级报告 | 2 声 明 一、本报告是联合资信基于评级方法和评级程序得出的截至发表之日的 独立意见陈述，未受任何机构或个人影响。评级结论及相关分析为联合资信 基于相关信息和资料对评级对象所发表的前瞻性观点，而非对评级对象的事 实陈述或鉴证意见。联合资信有充分理由保证所出具的评级报告遵循了真实、 客观、公正的原则。鉴于信用评级工作特性及受客观条件影响，本报告在资 料信息获取、评级方法与模型、未来事项预测评估等方面存在局限性。 二、本报告系联合资信接受安徽省皖能股份有限公司（以下简称"该公 司"）委托所出具，除因本次评级事项联合资信与该公司构成评级委托关系 外，联合资信、评级人员与该公司不存在任何影响评级行为独立、客观、公正 的关联关系。 三、本报告引用的资料主要由该公司 ...

安徽省皖能股份有限公司 （安徽省合肥市马鞍山路 76 号能源大厦） 2026 年面向专业投资者公开发行绿色 公司债券（第一期）发行公告 | 发行人： | 安徽省皖能股份有限公司 | | --- | --- | | 牵头主承销商/簿记管理人/受托管理人： | 中信证券股份有限公司 | | 联席主承销商： | 国泰海通证券股份有限公司、国元证券股份 | | | 有限公司、中国国际金融股份有限公司、申 | | | 万宏源证券有限公司 | 签署日期：2026年【2】月【4】日 本公司及其全体董事、监事、高级管理人员或履行同等职责的人员保证公 告内容真实、准确和完整。 重要事项提示 1、安徽省皖能股份有限公司（以下简称"发行人"、"本公司"、"公司"） 已于 2026 年 1 月 6 日获得中国证券监督管理委员会证监许可〔2026〕20 号文， 同意公司面向专业投资者公开发行面值不超过（含）99 亿元的公司债券。 2、本期债券为 3 年期，发行规模为不超过人民币 10 亿元（含），每张面值 为 100 元，发行数量为不超过 1000 万张（含 1000 万张），发行价格为人民币 100 元/张。 3、根据《证券法》等相 ...

安徽省皖能股份有限公司 2026 年面向专业投资者公开发行绿色公司债券（第一期）募集说明书 安徽省皖能股份有限公司 （安徽省合肥市包河区贵州路 491 号皖能智能管控中心 25-27 层） 2026 年面向专业投资者公开发行绿色公司 债券（第一期）募集说明书 | 发行人： | 安徽省皖能股份有限公司 | | --- | --- | | 牵头主承销商 | 中信证券股份有限公司 | | 联席主承销商 | 中国国际金融股份有限公司、国元证券股份 有限公司、国泰海通证券股份有限公司、申 | | | 万宏源证券有限公司 | | 受托管理人 | 中信证券股份有限公司 | | 本期债券发行金额： | 不超过人民币 亿元（含） 10 | | 增信措施情况： | 无增信 | | 信用评级结果： | 主体 AAA/债项- | | 信用评级机构： | 联合资信评估股份有限公司 | 牵头主承销商/簿记管理人/受托管理人： （住所：广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座） 联席主承销商： （住所：北京市朝阳区建国门外大街 1 号国 贸大厦 2 座 27 层及 28 层） （住所：上海市徐汇区长乐路 989 号 45 ...

安徽省皖能股份有限公司 2026 年面向专业投资者公开发行 绿色公司债券（第一期）更名公告 发行人于 2026 年 1 月 6 日获得中国证券监督管理委员会（证监许可【2026】 20 号）同意面向专业投资者公开发行面值不超过（含）99 亿元的公司债券的注 册。 本次债券申报时命名为"安徽省皖能股份有限公司 2025 年面向专业投资者 公开发行公司债券"。本次债券拟分期发行，属于绿色公司债券，根据命名规则， 本期债券名称更改为"安徽省皖能股份有限公司 2026 年面向专业投资者公开发 行绿色公司债券（第一期）"。 特此公告。 （以下无正文） 1 (本页无正文,为《安徽省皖能股份有限公司 2026 年面向专业投资者公开 发行绿色公司债券（第一期）更名公告》之盖章页） 安徽 a 唯能股份 本次债券名称变更不改变原签订的与本次债券相关文件的法律效力。前述法 律文件包括但不限于：《安徽省皖能股份有限公司 2025 年面向专业投资者公开发 行公司债券受托管理协议》《安徽省皖能股份有限公司 2025 年面向专业投资者公 开发行公司债券债券持有人会议规则》等。 2 ( 本页无正文, 为《安徽省皖能股份有限公司 2026 年 ...

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

（记者 曾健辉） 每经头条（nbdtoutiao）——仅老年独居者就数千万，谁能帮他们从容老去？意定监护在国内诞生已14 年，距全面落地还差"最后一公里" 每经AI快讯，皖能电力2月5日晚间发布公告称，因工作调整，方世清先生申请辞去公司董事及总经理 职务，此后，方世清先生将不在公司担任任何职务。 ...